Search the Site
Follow TheCancerLetter on Twitter
join our mailing list

Enter your name and email address to receive an update when we post new content.

IP Login

 

The Cancer Letter Inc.
PO Box 9905
Washington
DC 20016
Tel: 202-362-1809
Fax: 202-379-1787
publication date: May 6, 2016
ISSUE 18 - May 6, 2016 PDF



Virtual is Not Enough

FDA's Critics Call for Full Integration of Oncology Center Under Biden's Moonshot

The White House moonshot to accelerate progress in cancer research directs FDA to consolidate its oncology portfolio.

However, oncology insiders say the manner in which the presidential initiative will be implemented could make the difference between political balderdash and genuine improvement in FDA regulation of cancer therapies.

The entire controversy boils down to the interpretation of one word: Virtual.

Moonshot Director Addresses AAADV Workshop

Greg Simon, executive director of the cancer moonshot task force, addressed the FDA-sponsored workshop for Accelerating Anticancer Agent Development and Validation in North Bethesda, Md., May 4.

He discussed the goals for the moonshot initiative, how the program could fit into the next presidential administration, and how to take the project international.

      Slamming the Door

      Part XI: Gilman's Teachable Moment

      During our first conversation in the spring of 2012, Gilman said that he would go public unless he received assurances that CPRIT would retain its integrity after his departure.

      He wanted guarantees that the structure he built would not be turned into a political pigsty. With guarantees being hard to come by, it was obvious that he would end up slamming the door hard. Publicly.

      FDA to Regulate All Tobacco Products, Including E-Cigs, In Historic Expansion

      FDA issued final regulations for all tobacco products, including electronic cigarettes, cigars and hookah. The rules, with provisions aimed at restricting youth access and requiring premarket clearance for new products, will take effect Aug. 8.

      The federal regulations include: not allowing tobacco products to be sold to persons under the age of 18, both in person and online; requiring age verification by photo ID; not allowing the selling of covered tobacco products in vending machines, unless in an adult-only facility; and not allowing the distribution of free samples.

        National Academy of Sciences Elects 105 Members

        The National Academy of Sciences elected 84 new members and 21 foreign associates from 14 countries in recognition of their distinguished and continuing achievements in original research.

        Those elected today bring the total number of active members to 2,291 and the total number of foreign associates to 465. Foreign associates are nonvoting members of the academy.

          Funding Opportunity

          CureSearch Taking Applications
          For Pediatric Research Awards

          CureSearch for Children’s Cancer is taking applications for its International Grand Challenge Awards addressing three challenges in pediatric cancer treatment. The awards will be worth between $2 million and $3 million.

            In Brief
            • American Cancer Society and CVS Health launch three-year antismoking campaign
            • Pershing Square Sohn Research Alliance funds seven young investigators

            • Sean Parker recognized by the Vatican for philanthropic work

            • Richard O'Reilly receives inaugural Society of Memorial Sloan Kettering Prize

            • David Weiner receives professorship and grant from W.W. Smith Charitable Trust

            • Canadian Cancer Clinical Trials Network launches national awareness campaign

            Drugs and Targets
            • Eribulin receives EU approval in liposarcoma

            • Health Canada approves Lynparza in ovarian cancer

            • CHMP issues positive opinions for Imbruvica and Afinitor

            • AstraZeneca and Foundation Medicine to collaborate on diagnostic assays

            • AbbVie and CytomX Therapeutics to collaborate on probody drug conjugates

             


            Copyright (c) 2016 The Cancer Letter Inc.

            Letter